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ABSTRACT 
 
Dentin Matrix Protein 1(DMP1) is a non-collagenous phosphoprotein, belonging to the 
Small Integrin small integrin-binding ligand, N-linked glycoprotein (SIBLING) family, 
the deficiency or mutation of which results in Autosomal Recessive Hypophosphatemic 
Rickets, as evidenced by the accumulation of hypertrophic chondrocytes, resulting in 
immature or “premature” bone formation and mineralization.  
 
We employed cell lineage tracing (AggcretoDMP1-/-) together with other techniques to 
analyze the skeletal phenotype in DMP1 null mice at P10; these mice had shortened long 
bones and decreased circulatory levels of phosphate. While exogenous phosphate 
administration, in vitro, appeared to rescue the phenotype, we observed increased 
expressions of collagen 1 and osteopontin, together with high alkaline phosphatase activity 
(ALP) in the bone matrix, suggesting that these “accumulated” cells are actively 
differentiating into bone cells and secreting bone matrix; moreover, these bone cells were 
immature, and actively dividing, as indicated by decreased sclerostin (SOST) expression 
and increased Ki67 levels, respectively. However, while there was no apparent change in 
collagen 2 (Col2) and collagen 10 (Col10) expression, and Endomucin activity, Osterix 
and Runx2 levels were higher in the DMP1 control than in the KO.  
 
In conclusion, there is increased chondrogenesis in a “hypophosphate” environment in 
DMP1 null mice; here, hypertrophic chondrocytes “persist” and differentiate rapidly into 
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immature bone cells (they do not apoptose as previously believed). While exogenous 
phosphate positively influenced the secondary ossification center in long bones, further 
studies at different time points are necessary to demonstrate such an effect. Moreover, to 
demonstrate the influence of phosphate rich diet on phenotype, cell lineage tracing studies 
are warranted to study the cell transformation from chondrocytes to bone cells. 
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NOMENCLATURE 
 
DMP1  Dentin Matrix Protein 1 
FGF23 Fibroblast Growth Factor  
PHEX Phosphate-regulating gene with Homologies to Endopeptidases        
                                    on the X chromosome 
IHH Indian Hedge Hog 
PTHRP Parathyroid hormone related peptide 
PPR Signaling            Parathyroid hormone and Parathyroid hormone related peptide  
                                    signaling  
ARHR                         Autosomal Recessive Hypophosphatemic Rickets               
Cbfa1 core-binding factor subunit alpha-1 
Runx2 Runt-related transcription factor 2 
Dmp1- (KO)  Dentin Matrix Protein Gene Knock out 
Aggcreto                     Aggrecan-Cre ERT2 and Rosa26 tdTomato 
EDTA Ethylene Diamine Tetra-acetic Acid 
TRAP                         Tartrate-resistant acid phosphatase 
ALP                            Alkaline Phosphatase 
COL1                          Collagen 1 
COL2                          Collagen 2 
COL10                        Collagen 10 
OPN                            Osteopontin 
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OSX                               Osterix 
EDU                               5-Ethynyl-2´-deoxyuridine 
DAPI                             4',6-diamidino-2-phenylindole 
IHC                               Immuno Histo-Chemistry  
IF                                  Immunofluorescence 
X–ray                            X-radiation                
NaoH  Sodium hydroxide  
NIH  National Institute of Health 
OCT  Optimal cutting temperature compound 
PBS  Phosphate-buffered saline 
SEM  Scanning electron microscopy 
SIBLINGs  Small Integrin-Binding Ligand N-liked glycoproteins  
TGF-β1  Transforming growth factor beta-1 
Pi                                  Inorganic Phosphate 
IACUC                         Institution of Animal Care and Use Committee 
PFA                              Paraformaldehyde 
PBST                            Phosphate Buffered Saline with Tween 20 
ALP                              Alkaline Phosphatase  
BV/TV                          Bone Volume / Total Volume 
mM                               Milli Molar 
βGP                               Beta Glycero Phosphate 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
Human bones, for the most part, form by endochondral ossification wherein cartilage is 
replaced by bone, a complex process involving a definite sequence of differentiation of 
chondrocytes in the growth plate of long bones. To further elaborate, resting chondrocytes 
in the germinal zone of the growth plate begin to proliferate, then transform into 
prehypertrophic, and then hypertrophic chondrocytes, followed by calcified cartilage 
formation and its invasion by bone marrow. The cartilage is then resorbed and eventually 
replaced by subchondral bone (A, 1991; Kronenberg, 2003). These steps are regulated by 
many transcription factors and signaling pathways, under the influence of growth factors, 
hormones, and their specific receptors (Goldring, Tsuchimochi, & Ijiri, 2006) 
 
Although the current dogma that hypertrophic chondrocytes undergo apoptosis is still 
widely held (de Crombrugghe, Lefebvre, & Nakashima, 2001), recent evidence suggests 
that these chondrocytes directly transform into bone cells, rather than undergoing 
apoptosis, during endochondral ossification (Jing et al., 2015). However, this emerging 
concept warrants further elucidation on the genetic and molecular underpinnings that 
ultimately influence such fate.  
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The regulation of chondrogenesis is complex and involves several molecular factors such 
as transcription factors, signaling molecules and epigenetic factors. 
  
Indian hedgehog (Ihh) is one of several factors that regulates chondrogenesis. Expressed 
by prehypertrophic chondrocytes, it accelerates chondrocytic differentiation, an effect that 
is counter-balanced by FGF23. Parathyroid hormone-related peptide (PTHRP), another 
potent factor, maintains chondrocyte proliferation rate (J. Guo, Chung, Kondo, Bringhurst, 
& Kronenberg, 2002; Kobayashi et al., 2002) by acting through the PTHRP receptor 
(Chung, Lanske, Lee, Li, & Kronenberg, 1998; Karaplis et al., 1994; Lanske et al., 1996) 
via the secondary messenger cAMP pathway. The latter in turn modulates gene expression 
by PKA-dependent phosphorylation of the CREB gene at Ser 133(Gonzalez & Montminy, 
1989)which ultimately affects Ptch expression in proliferating chondrocytes, unlike Ihh. 
Deletion of the CREB gene results in death of the neonate owing to defects in lung 
maturation(Rudolph et al., 1998). Activity of PTH/PTHrP (PPR) signaling is also 
dependent on Ihh in blocking premature hypertrophic differentiation of columnar 
chondrocytes (Figure 1,2) (Chung, Schipani, McMahon, & Kronenberg, 2001; Lanske et 
al., 1996; Vortkamp et al., 1996).  In addition, Ihh helps in stimulating the differentiation 
of periarticular (resting) chondrocytes into proliferating chondrocytes, a process 
independent of PTHRP (Karp et al., 2000). 
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Figure 1: PPR signaling: PPR signaling controls negatively the differentiation of 
periarticular chondrocytes to columnar chondrocytes (arrow 1) and it also blocks the 
terminal differentiation of columnar chondrocytes (arrow 2). Reprinted with permission 
from Kobayashi et al…2002 
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Figure 2: PTHrP -IHH feedback loop: a. Premature hypertrophic chondrocyte 
differentiation is directly blocked by PTHrP signaling. b. PTHrP is positively regulated 
by IHH in the periarticular region. c. PTHrP positively influences the columnar formation 
of chondrocytes between periarticular region and the IHH domain’s. d. Ihh action 
stimulates early chondrocyte proliferation and differentiation, thereby increasing their 
numbers. Reprinted with permission from Kobayashi et al…2002 
 
 
 Of significance are BMPs, members of the TGFβ superfamily that play a major role in 
chondrocyte proliferation and differentiation (Massague, 2012; Massague & Wotton, 
2000). BMP’S are essential for early limb development, in addition to being found in the 
perichondrium (BMP – 2,3,4,5,7), and proliferative (BMP – 7) and hypertrophic 
chondrocytes (BMP – 2,6)(Kugimiya et al., 2005; Shen et al., 2015). Functionally, BMPs 
induce the phosphorylation of Smads after they bind to their serine–threonine kinase 
activity cell-surface receptors. Following nuclear translocation, smads bind to their target 
genes(Li et al., 2003). There are mainly two types of BMP receptors - BmpR-IA and 
BmpR-IB. While BmpR-IB activity is necessary in the initial stages of chondrogenesis 
and in regulating apoptosis(Graham, Francis-West, Brickell, & Lumsden, 1994; Zou & 
Niswander, 1996), BmpR-IA is required in the later stages of chondrogenesis 
 5  
(prehypertrophic chondrocytes) and its signaling through the perichondrium(Kingsley, 
1994) regulates Ihh–PTHRP signaling axis. 
 
Further, Wnt/β-catenin signaling is required for normal cartilage and bone formation(Day, 
Guo, Garrett-Beal, & Yang, 2005). Intercellular cell signaling between or within 
condensed mesenchymal cells (from which osteoblasts and chondrocytes develop) play an 
important role in cell differentiation and Wnt expression in different stages of 
endochondral ossification suggests its role in cellular differentiation(X. Guo et al., 2004; 
Kato et al., 2002; Parr, Shea, Vassileva, & McMahon, 1993).  Wnt signaling results in 
elevated cytoplasmic β–catenin and its subsequent translocation to the nucleus to begin 
transcription of TCF/LEF transcription factor family members (Logan & Nusse, 2004) to 
cause osteoblast differentiation, and inhibiting the activity of β–catenin causes 
commitment of cells to a chondroblastic lineage (Figure 3). 
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Figure 3: Wnt Signaling: Left panel shows degradation of βcatenin through interaction 
of Axin, GSK3, APC without Wnt signaling. Right panel shows binding of Wnt to cell 
surface Frizzled receptor complex which transduce a signal to Axin, GSK3, APC and to 
Dishevelled (Dsh). The result is that βcatenin degradation is inhibited and it accumulates 
in cytoplasm and nucleus. Then it interacts with TCF and causes / controls transcription. 
Reprinted with permission from Roel Nusse et al…2005. 
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Figure 4:  Wnt Signaling and cell differentiation: Mesenchymal precursor stem cells 
and condensations which has ability to differentiate in to cartilage and bone are labelled 
pink, the chondrocytes blue. In the precursor cells determined to form bone 
(intramembranous ossification) there is higher Wnt signaling, Runx2 expression is 
upregulated and Sox 9 is downregulated. In the precursor cells determined to form 
cartilage template first, followed by bone (endochondral ossification), there is lower Wnt 
signaling, Sox 9 upregulation and Runx2 downregulation. Later Wnt signaling is 
upregulated, Runx2 is upregulated from perichondrium, thereby contributing to bone 
formation. Reprinted with permission from Day et al.......2005 
 
Transcription factors such as cbfa1/ Runx2, which belongs to runt (Ducy, Zhang, 
Geoffroy, Ridall, & Karsenty, 1997) family, is known to stimulate osteoblast 
differentiation,(Komori et al., 1997) . Recent studies show that cbfa1 also stimulates 
hypertrophic chondrocyte maturation, and contributes to chondrocyte differentiation, as 
cbfa1 homozygous mutations were shown to develop phenotypes completely devoid of 
bone, while heterozygous mutations have been shown to develop cleidocranial dysplasia 
(Mundlos, Huang, Selby, & Olsen, 1996). In addition, they developed cartilage anomalies 
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causing chondrodysplasias in mice. (Ducy et al., 1997; Enomoto-Iwamoto, Enomoto, 
Komori, & Iwamoto, 2001; Leboy et al., 2001; Otto et al., 1997).  Cbfa1 is a positive 
regulator of chondrogenesis and is known to exert its effect through 3 different 
mechanisms: first, by direct expression in prehypertrophic and hypertrophic chondrocytes; 
second, through indirect signaling by perichondral cells; third, through a combination of 
the above i.e. mechanisms 1 and 2(Kim, Otto, Zabel, & Mundlos, 1999).  
 
Sox-9, another important transcription factor expressed in proliferative and pre-
hypertrophic chondrocytes, determines cell fate during early chondrogenesis.  Sox-5 & 
Sox-6 are also co expressed with Sox 9 in chondroprogenitor cells(Lefebvre, Huang, 
Harley, Goodfellow, & de Crombrugghe, 1997). Inactivation of Sox-9 before 
mesenchymal condensation disturbs not only the cartilage formation but also 
endochondral ossification(Akiyama, Chaboissier, Martin, Schedl, & de Crombrugghe, 
2002; Bi, Deng, Zhang, Behringer, & de Crombrugghe, 1999) by disrupting Runx2 
transcript which is necessary for osteoblast differentiation. It acts by binding to specific 
sequences in the collagen 2 α 1 and collagen 2 α XI gene and can enhance the activity in 
non chondrocytic areas too.  
 
Apart from transcription factors, gene transcription also depends on histone modifications 
in cartilage development (Kubicek & Jenuwein, 2004; Martin & Zhang, 2005; Strahl & 
Allis, 2000). Tri-methylation of lysine 27 on histone H3 (H3K27me3) signifies the 
transcriptional regression and is established by enhancer of zeste homolog 2 (EZH2), a 
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core subunit of the polycomb repressive complex 2 (PRC2) (Czermin et al., 2002; Muller 
et al., 2002). Previous studies have identified Jumonji domain-containing proteins UTX 
(KDM6A) and JMJD3 (KDM6B) as H3K27me3-specific demethylases, implying that 
polycomb mediated gene silencing can be regulated and is reversible (Agger et al., 2007; 
De Santa et al., 2007; Hong et al., 2007). Histone deacetylase HDAC4 and H3K9 
methyltransferase ESET inhibit chondrocyte hypertrophy in vivo but their role in cellular 
proliferation is not known(Vega et al., 2004; D. Yang, Okamura, Nakashima, & Haneji, 
2013). Genetic and biochemical studies show that JMJD3 promotes both proliferation and 
hypertrophy by interacting with Runx2 as JMJD3 cannot bind to DNA by itself; so Runx2 
helps in recruiting JMJD3 to the specific site (Figure 5). JMJD3 interacts with N – 
terminus of Runx2 to enhance its action, thereby helping in chondrocyte differentiation. 
Hence, JMJD3 acts as an important epigenetic factor in cartilage development(F. Zhang 
et al., 2015). 
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                Figure 5: JMJD3 and Endochondral bone formation: a.H3K27me3 
modification enables the repression of transcription of target gene Runx2 and Ihh in 
chondrocytes.b. JMJD3 counteracts the H3K27me3 modification and facilitates the 
transcription of Runx2 in chondrocytes. Reprinted with permission from Zhang F et 
al……2015 
 
 
Gsα, a heterotrimeric stimulatory protein which binds to adenyl cyclase to form Cyclic 
AMP, is encoded by the GNAS gene in mice and its mutation in humans results in Albright 
Hereditary Osteodystrophy (Bastepe et al., 2004; Mantovani, Spada, & Elli, 2016; Turan 
& Bastepe, 2015) This protein is thought to be a negative regulator of chondrogenesis as 
mutations in this gene causes severe epiphyseal defects and growth plate retardation. It is 
thought to exert its action by acting on the PTHRP-PTH receptor in growth 
plates(Sakamoto, Chen, Kobayashi, Kronenberg, & Weinstein, 2005). 
 
Matrilins (MATN1, MATN2, MATN3, MATN4) (Klatt et al., 2000) belongs to a family 
of four non-collagenous proteins that share similar structural motifs (Deak, Wagener, Kiss, 
& Paulsson, 1999; Klatt et al., 2000). While MATN1 and MATN3 are specific to 
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cartilage(Wagener, Kobbe, & Paulsson, 1997), MATN2 and MATN4 have a wider 
distribution.  MATN3 has the simplest structure among other matrilin members. It 
contains a single vonWillebrand factorA (vWFA) domain, a C-terminal coiled-coil 
domain, and four epidermal growth factor (EGF)-like domains which mediates 
oligomerization(Wagener et al., 1997) (Figure 6). It is thought to play a structural role by 
binding to cartilaginous ECM proteins Col II and Col IX(Fresquet et al., 2007). It also 
regulates chondrogenesis via an interleukin receptor antagonist-dependent 
mechanism(Jayasuriya, Goldring, Terek, & Chen, 2012; Pei, Luo, & Chen, 2008). 
MATN3 inhibits premature hypertrophy by binding to the BMP2 receptor and decreasing 
SMAD 1 activity (Figure 7). 
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Figure 6: MATN3 and BMP-2 interaction: Diagram represents that the coiled coil 
domain and 2 EGF like domains of MATN3 are necessary for BMP-2 signal inhibition. 
Reprinted with permission from Xu Yang et al….2014 
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Figure 7: MATN3 chondrocyte hypertrophy regulation through BMP-2 signaling:  
MATN3 binds to BMP-2 via the EGF domains in the coiled-coil domain. This binding 
inhibits the activation of Smad 1, its translocation in to the nucleus and thereby binding 
with Col10 gene with Runx2 transcriptional activity, finally inhibiting chondrocyte 
hypertrophy. Reprinted with permission from Xu Yang et al….2014 
The role of phosphates in mineralization of cartilage is well-known. Optimal phosphate 
concentration is necessary to maintain sufficient circulatory levels and in the initial 
formation of hydroxyapatite crystals. Classically, whereas phosphate homeostasis is 
controlled by parathyroid hormone and vitamin D by regulating its intestinal absorption 
and its reabsorption in the kidneys(Schiavi & Kumar, 2004; Tenenhouse, 1997). FGF23 
is a phosphaturic hormone, which is mainly produced by osteocytes in bone. FGF23 is 
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present in many tissues like liver, thymus, parathyroid, bone, heart(Shimada et al., 2001; 
Yamashita, Yoshioka, & Itoh, 2000),(Saito et al., 2003) thereby contributing to phosphate 
balance in the body. Thus, taken together, these implicate bone as an ‘endocrine organ’ 
that functions via a complex bone-kidney axis.  
 
DMP1 is a non-collagenous phosphoprotein of the SIBLING family(Fisher LW, 2003), a 
deficiency or mutation of which leads to cartilage defects in mice and Autosomal 
Recessive Hypophosphatemic Rickets (ARHR) in humans (Ye et al., 2005), the latter 
being associated with increased levels of FGF23, thereby resulting in renal phosphate 
wasting (Feng et al., 2006). Mutations in (PHEX) phosphate regulating gene with 
homologies to endopeptidases on the X chromosome) have also been associated with X-
linked hypophosphatemia (Makras, Hamdy, Kant, & Papapoulos, 2008; Sabbagh, 
Carpenter, & Demay, 2005; Yuan et al., 2008). Both these conditions occur through a 
common pathway of decreased phosphate levels in blood secondary to increased FGF23 
levels. Further, FGF23 mutations are known to cause Autosomal Dominant 
Hypophosphatemic Rickets (Liu et al., 2008) by decreasing the proliferating chondrocytes 
and increasing the differentiation to hypertrophic chondrocytes, thereby causing 
achondroplasia(Colvin, Bohne, Harding, McEwen, & Ornitz, 1996; Deng, Wynshaw-
Boris, Zhou, Kuo, & Leder, 1996). Regardless, all the three mutations lead to defects in 
cartilage and bone formation and exhibit low phosphate levels in circulation and show 
expanded growth plate, decreased apoptosis of the hypertrophic chondrocyte 
zone(Sabbagh et al., 2005). Previous studies conducted in rachitic rats showed that 
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phosphate is preferentially sequestrated relative to calcium in the hypertrophic 
zone(Howell, Pita, Marquez, & Madruga, 1968) and the size of inorganic phosphate 
crystals determines the degree of conversion of demineralized to mineralized 
cartilage(Bingham & Raisz, 1974; Kakuta, Golub, & Shapiro, 1985). Studies done in 
calcium sensing receptor knock out mice, that exhibited hyperparathyroidism due to 
impaired calcium sensing, showed hypophosphatemia and rachitic changes despite 
hypercalcemia(Tu et al., 2003). All the above studies clearly indicate a correlation 
between low phosphate levels and rachitic changes in mice. 
 
Stanniocalcin, a glycoprotein initially identified in fish (Wagner, Hampong, Park, & Copp, 
1986), regulates calcium metabolism (Wagner, Milliken, Friesen, & Copp, 1991) by 
preventing hypercalcemia and causing phosphate reabsorption through kidneys (Lu, 
Wagner, & Renfro, 1994). Following its identification in mice and humans(Chang et al., 
1995; Olsen et al., 1996) this protein was shown to have a more profound effect on 
phosphate (Madsen et al., 1998; Wagner et al., 1997) than calcium metabolism via 
sodium-dependent phosphate transporter activity. It is distributed throughout the body in 
the lungs, heart, bone, kidney, thyroid, and intestine) (De Niu et al., 2000; Wagner, 
Guiraudon, Milliken, & Copp, 1995; Worthington et al., 1999). Previous phosphate 
studies indicate that high intracellular phosphate levels induce chondrocyte 
apoptosis(Magne et al., 2003; Mansfield, Rajpurohit, & Shapiro, 1999; Mansfield, 
Teixeira, Adams, & Shapiro, 2001; Rajpurohit, Mansfield, Ohyama, Ewert, & Shapiro, 
1999) by activating caspase 9 (Sabbagh et al., 2005) and disrupting the mitochondrial cell 
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membrane. Increased phosphate levels also inhibit cbfa1, thereby inhibiting 
chondrogenesis (Enomoto et al., 2000; Fujita et al., 2001; Hoshi, Komori, & Ozawa, 
1999). Stanniocalcin also inhibits FGF23, causing increased phosphate uptake by 
chondrocytes via Na–II pi transporter activity, thereby inhibiting chondrogenesis at the 
growth plate. 
 
Previous invitro studies confirmed that 7Mm phosphate concentrate in cultures is 
sufficient to induce caspase 9 mitochondrial apoptosis of hypertrophic 
chondrocytes(Mansfield et al., 1999) and it is differentiation dependent as the same 
concentration did not induce apoptosis in chondrocytes where the terminal differentiation 
did not take place(Sabbagh et al., 2005). This inhibition was due to lack of vascular 
invasion suggesting that phosphate is necessary in every step of endochondral ossification 
(Zalutskaya, Cox, & Demay, 2009). 
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     CHAPTER II 
MAJOR HYPOTHESIS 
The human appendicular skeleton forms by endochondral ossification wherein cartilage is 
replaced by bone, a complex process involving a definite sequence of differentiation of 
chondrocytes in the growth plate of long bones. To further elaborate, resting chondrocytes 
in the germinal zone of the growth plate begin to proliferate, then transform into 
prehypertrophic, and then hypertrophic chondrocytes, followed by calcified cartilage 
formation and its subsequent invasion by bone marrow. The cartilage is then resorbed and 
eventually replaced by subchondral bone (A, 1991; Kronenberg, 2003). These steps are 
regulated by many transcription factors and signaling pathways, under the control of 
growth factors and hormones, and their specific receptors (Goldring et al., 2006). While 
the current dogma maintains that hypertrophic chondrocytes undergo apoptosis (de 
Crombrugghe et al., 2001), recent evidence suggests that these chondrocytes directly 
transform into bone cells, rather than undergoing apoptosis during endochondral 
ossification (Jing et al., 2015). However, further elucidation on the genetic and molecular 
underpinnings that ultimately influence such fate, in endochondral ossification, is 
warranted. 
2.1 Molecular Biology of Chondrocytes 
The regulation of chondrogenesis is complex and involves several molecular factors such 
as transcription factors, signaling molecules and epigenetic factors. It is well-established 
18 
that Indian Hedgehog accelerates chondrocyte differentiation, balanced by FGF23 which 
retards chondrocyte differentiation, and parathyroid hormone-related peptide (PTHRP), 
that maintains the proliferation rate of chondrocytes (J. Guo et al., 2002; Kobayashi et al., 
2002; Kronenberg, 2003). On the other hand, transcription factors such as Runx2 stimulate 
hypertrophic chondrocyte maturation and contribute to chondrocyte differentiation (Ducy 
et al., 1997; Enomoto-Iwamoto et al., 2001; Leboy et al., 2001; Otto et al., 1997).  Further, 
Wnt/β-catenin signaling is required for normal cartilage and bone formation (Day et al., 
2005). 
2.2 Role of Phosphates in Regulating chondrocyte fate 
The role of phosphates in cartilage mineralization is well-known. Optimal phosphate 
concentration is necessary to maintain sufficient circulatory levels and in the initial 
formation of hydroxyapatite crystals. Classically, whereas phosphate homeostasis is 
known to be controlled by parathyroid hormone and vitamin D by regulating intestinal 
absorption of phosphate and its reabsorption in the kidneys (Schiavi & Kumar, 2004),  
FGF23, which is mainly produced by osteocytes in bone, is a phosphaturic hormone. 
FGF23 is present in many tissues like liver, thymus, parathyroid, bone and heart (Shimada 
et al., 2001; Yamashita et al., 2000) and regulates phosphate metabolism by inhibiting Na-
II pi co-transporter activity (Saito et al., 2003), thereby contributing to phosphate balance 
in the body. Thus, bone appears to function as an ‘endocrine organ’ via a complex bone-
kidney axis. 
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DMP1 is a non-collagenous phosphoprotein of the SIBLING family (Fisher LW, 2003), a 
deficiency/mutation that leads to cartilage defects in mice and Autosomal Recessive 
Hypophosphatemic Rickets [ARHR] in humans (Ye et al., 2005), the latter being 
associated with increased levels of FGF23, thereby resulting in renal phosphate wasting 
(Feng et al., 2006). Mutations in (PHEX) phosphate regulating gene with homologies to 
endopeptidases on the X chromosome have also been associated with X-linked 
hypophosphatemia (Liu et al., 2008; Makras et al., 2008; Sabbagh et al., 2005; Yuan et 
al., 2008). Both these conditions occur through a common pathway of decreased 
phosphate levels in blood secondary to increased FGF23 levels. Further, FGF23 mutations 
are known to cause ARHR (Liu et al., 2008) by decreasing the number of proliferating 
chondrocytes and increasing their differentiation to hypertrophic chondrocytes, thereby 
causing achondroplasia (Colvin et al., 1996; Deng et al., 1996). Regardless, all the three 
mutations exhibit low phosphate levels in circulation, cause defects in cartilage and bone, 
and expanded growth plates with decreased apoptosis of the hypertrophic chondrocyte 
zone (Sabbagh et al., 2005).  
 
Previous studies conducted in rachitic rats showed that phosphate is preferentially 
sequestered relative to calcium in the hypertrophic zone of the growth plate (Howell et al., 
1968), and the size of inorganic phosphate crystals determines the degree of conversion 
of demineralized to mineralized cartilage (Bingham & Raisz, 1974; Kakuta et al., 1985). 
Studies on calcium-sensing receptor knockout mice have indicated that these mice exhibit 
hyperparathyroidism due to impaired calcium sensing, hypophosphatemia, and rachitic 
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changes despite hypercalcemia (Tu et al., 2003). All the above studies clearly indicate a 
correlation between low phosphate levels and rachitic changes in mice.  
 
It is believed that decreased phosphate levels lead to decreased chondrogenesis, and 
decreased apoptotic rates in the hypertrophic chondrocyte layer. These effects result in the 
accumulation of hypertrophic chondrocytes, causing a further decrease in bone formation 
and maturation: such effects essentially attributable to defective chondrogenesis. By 
contrast, the proliferation layer of chondrocytes is wider (Lin et al., 2014). In addition, the 
bone in the subchondral regions and cortical compartments of long bones in DMP1-
knockout (KO) mice is immature with high alkaline phosphatase activity (Feng et al., 
2006). To date, no study has been able to offer a convincing explanation for the presence 
of an expanded hypertrophic chondrocyte layer, and the accumulation of poorly 
mineralized bone, in DMP1 KO mice. Hence, further elucidation is warranted. 
 
2.3 Aims and Objectives 
In this study, cell-lineage tracing techniques will be combined with multiple cellular and 
molecular approaches, to test the central hypothesis: 1) Low phosphate levels inhibits 
chondrogenesis and cell transformation from chondrocytes into bone cells; and 2) Low 
phosphate levels inhibits bone cell maturation.  
 
Specific Aim 1 - Define chondrocyte fate in DMP1 KO mice (Hypophosphatemia model) 
using cell-lineage tracing techniques and other approaches. 
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Conventional DMP1 null mice that also harbor Aggrecan-CreERT2 and Rosa26tdTomato will 
be used.  In this way, the fate of chondrocytes in the DMP1 null mice can be traced after 
activating the cre event. Other approaches include digital radiography, µCT, 
Immunohistochemistry, Toluidine blue/ TRAP/ Alkaline Phosphatase Staining, and 
confocal microscopy to detect co-localization of COL1/ COL2/ COL10/ ENDOMUICN/ 
OSTERIX/ EDU/ OSTEOPONTIN/ KI67/RUNX2 
 
Specific Aim 2 - To define the impact of Pi levels (low and high Pi) on secondary 
ossification formation using the metatarsal organ culture model. 
For this, 10-day old metatarsal rudiments will be harvested from DMP1 null mice and 
DMP1 control mice and cultured at varying phosphate concentrations; concentration-
dependent effects on the formation of secondary ossification centers will be looked for 
using digital radiography. 
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2.4 Rationale 
It is hypothesized that decreased phosphate levels inhibit chondrogenesis; using cell-
lineage tracing, the chondrocyte cell line can be traced from the resting zone to the 
hypertrophic zone (until bone formation) of the growth plate, after which it should be 
assessible whether the observed phenotype (in Aggrecan-Cre to DMP1 null mice) is due 
to a defect in endochondral ossification, or intramembranous ossification; any defect or 
delay in the cell transformation to bone cells will be traced. 
The above-mentioned cell line combined with in vitro approaches will be used to test the 
hypothesis. 
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                                                               CHAPTER III 
                                                 MATERIAL AND METHODS 
3.1 Development of Mice 
The fate of the post-natal chondrocytes in subchondral bone formation and its relationship 
to phosphate was studied by generating triple mice lines using the following strains Agg-
CreERT2 (Henry et al., 2009; G. Yang et al., 2005), DMP1-/-, and Rosa26tdTomato (B6;129S6-
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J, stock number: 009705; Jackson Laboratory, 
Bar Harbor, ME, USA) as described previously (Jing et al., 2015),  (Soriano, 1999) and 
internally cross breeding the mice lines thrice. Dmp1-/- mice with exon 6 deletion were 
generated as described previously.(Feng et al., 2006). All the animals(mice) that were used 
for this study were maintained under the guidelines established by the Institution of 
Animal Care and Use Committee (IACUC, Texas A&M University College of Dentistry), 
which carry out required approval for all the procedures used in this study. All the pups 
were induced once with Tamoxifen at P3 (7.5µl /1 gm of body weight) and sacrificed at 
10 days of age. Tamoxifen (T5648; Sigma-Aldrich, St. Louis, MO, USA) was dissolved 
in 10% ethanol and 90% corn oil (C8267; Sigma-Aldrich) as described previously (Jing 
et al., 2015).  4 mice were used in each group for each specific aim, along with controls 
which contain DMP1 (DMP1+/+). All the mice lines were generated in a C57BL/6 
background. The mice were fed with autoclaved Purina rodent chow (5010; Ralston 
Purina, St Louis, MO, USA) containing calcium, 0.67% phosphorus, and 4.4 IU of vitamin 
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D per gram. For observing the cell proliferation rate, 5–ethynyl–2′–deoxy uridine (EDU) 
was injected [at 3ml/gm of body wt.] 24 hours before sacrifice. 
 
3.2      Digital Radiography (X-Ray) and Micro-Computed Tomography 
The skeletons of DMP1 mice and DMP1-null mice were examined using digital 
radiography (Faxitron MX-20DC12 system; Faxitron Bioptics, Lincolnshire, IL, USA) at 
10 days after fixation in 4% paraformaldehyde (PFA) for 24 hours, followed by fixation 
in 0.5% PFA. The tibias were scanned in a µ-CT imaging system (35, Scanco Medical, 
Bassersdorf, Switzerland) as described previously (Ye et al., 2005). Tibia cortical bone 
and whole bone data were quantified using a µCT imaging system. Serial tomographic 
imaging at an intensity of 145 μA and energy level 55Kv for the tibia was done. For this 
purpose, cortical bone from 120 cross-sectional slices above the mid-shaft of the tibia was 
analyzed. The threshold used for this analysis was 200. Bone volume/total volume [BMD] 
at the mid-shaft was also calculated and used for comparison between the samples. The 
porosity, and apparent and material densities were also obtained. For calculating the 
trabecular bone volume, a total of 183 slices below the growth plate area and above the 
mid shaft area was analyzed. The porosity, apparent and material densities, and bone 
volume/total volume [BMD] was obtained, calculated and used for comparison between 
the samples. 
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3.3 Histology    
Toluidine Blue Staining     
To prepare frozen sections, the specimens were first fixed in 4% PFA in PBS (at pH 7.4) 
for 24 hours, then transferred to 0.5% PFA in PBS (at pH 7.4). Further decalcification of 
specimen in 17% EDTA was done. Then, the samples were immersed in 30% sucrose 
overnight, later embedded in OCT and left for 30 minutes to freeze up in the cryostat. 
Finally, the samples were sectioned into 10µm sections. The sections were dried for 40 
minutes at room temperature and later stored at – 20 οC, pending staining or 
immunofluorescence, or till other procedures were done.  
 
For any staining procedures, the sections were incubated in 37 οC for 10 minutes, then at 
room temperature for another 2-3 minutes, washed with distilled water twice for 5 minutes 
at room temperature to hydrate the slides and to remove OCT. After washing, the slides 
were stained in toluidine blue working solution for 5 minutes and once again washed in 
distilled water till clear. After staining, a series of dehydration steps were followed: first 
dipping the slides in 80% alcohol for 30 seconds, then air dried; a second dip in 100% 
alcohol twice for 3 minutes, then air dried; a final dip in Xylene twice for 2 minutes, then 
air dried; the slides were then cover-slipped with permount and left to dry overnight, 
before being observed under microscope. 
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TRAP Staining 
After the slides were hydrated and the OCT removed, 2 Coplin jars A & B containing 40 
ml of trap buffer 1 [(Sodium acetate anhydrous (sigma S-2889) – 9.2 gm, L tartaric acid 
(sigma T-6521) – 11.4 gm, distilled water – 950ml, glacial acetic acid (sigma 320099), 
with PH  adjusted to between 4.7-5.0 using 5M sodium hydroxide] were incubated at 37 
οC for 15-20 minutes; then buffer II [Naphthol AS-BI phosphate (sigma N-2125) – 20 mg 
& Ethylene glycol monoethyl ether (sigma E-2612) – 1ml ]  is added to jar A and the slides 
are immersed into the jar and incubated for 45 minutes with the Jar B still remaining in 
the incubator for an additional 45 minutes along with Jar A. Then, just before 45 minutes 
lapsed, Buffer III [ sodium nitrite (sigma S-2252) – 40 mg, distilled water – 1ml] and 
Buffer IV [ Parasoniline chloride (Basic Fuschin, Sigma P–3750) – 50 mg, distilled water 
– 834µl, Hcl – 166 µl] were prepared. Buffer IV was heated for 5 minutes at 55 οC and 
filtered. The two buffers were then mixed for 30 secs and allowed to stand still for 2 
minutes. Later, this combined mixture was added to jar B and the slides from jar A are 
then transferred to Jar B immersed for 10 seconds and then washed in distilled water to 
stop the reaction; the slides were then observed under microscope. Finally, the slides were 
counterstained with methylene green for 5 minutes, washed with distilled water and the 
series of dehydration steps followed in the same way, as described for Toluidine Blue 
staining. 
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Alkaline Phosphatase Staining 
Alkaline Phosphatase is an enzyme which determines the amount of osteoblastic activity 
(greater the staining intensity, more is the osteoblastic activity).  
 
After the slides were brought to room temperature, they were washed with PBS for 5 
minutes; the slides were first incubated in PBST at 37 οC for 5 minutes, then incubated in 
ALP staining buffer for 10-30 minutes, depending on the staining intensity. After the 
slides were washed with PBS [to stop the staining reaction], they were observed under 
microscope; slide counter staining with methylene green for 5 minutes was done and the 
dehydration steps were followed, as described above. Finally, the slides were cover 
slipped, and allowed to dry overnight in preparation for imaging the next day. 
 
3.4 Immunostaining and Immunofluorescence 
Immunostaining was done with different primary and secondary fluorescent antibodies. 
The frozen slides were incubated at 37 οC for 10 minutes, left at room temperature for 3 
minutes, and then washed in distilled water twice for 5 minutes. After that they were 
incubated with IHC working solution at 37 οC for 40 minutes, slides were washed with 
PBS, 3 times, for 3 minutes; then, for a polyclonal primary antibody, the blocking solution 
(prepared using 3% BSA, 20% goat serum and PBS) was added to slides, and incubated 
for 1 hour at room temperature. Then, the blocking solution was removed carefully using 
blotting paper and the primary antibody was added according to the working range 
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concentration; the slides were then incubated at 4 οC, overnight. On day 2, the slides were 
washed with PBS 3 times for 3 minutes, and the secondary antibody (in the concentration 
of 1:200, 4% goat serum, PBS) were used and the slides were incubated at room 
temperature for 2 hours, then washed with 1% PBS 3 times for 3 minutes; the slides were 
mounted using DAPI mounting medium and allowed to dry. For immunolocalization, the 
following antibodies were used: anti-col1 rabbit polyclonal antibody (1:100; Abcam, 
Cambridge, England), anti-Col2 mouse monoclonal antibody (1:50; Santa Cruz 
Biotechnology, Dallas, TX, USA),  anti-Col10 rabbit polyclonal antibody (1:100; 
provided by Dr. Natasha Cherman from NIH) ), anti-SOST antibody (1:100; R&D 
systems), anti- KI67 antibody (1:100 Thermo Fischer Laboratories, USA), anti- Runx2 
antibody( 1:400; cell signaling technologies, USA), anti- Osterix antibody (1:400 Abcam 
; USA), anti- Endomucin antibody (1:100 Abcam ; USA) 
3.5 Confocal Microscopy 
All fluorescent cell images were captured at wavelengths ranging from 488 (green) – 561 
(red) nm, using an SP5 Leica Confocal Microscope. Multiple, stacked images were taken 
at 200Hz (1024 x 1024) and the different chondrocyte zones [and their contribution to 
subchondral bone formation] were observed. 
3.6 In vitro (Metatarsal) Organ Culture 
For culture, the three central metatarsal bone rudiments were dissected out from the hind 
limbs of 10-day old DMP1 null mice and their age-matched control litter mates and 
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cultured in a 24-well plate [one bone per well], as described previously (R. Zhang et al., 
2011).  
 
3.7 Statistical Analysis 
As the groups were homogenous, a total number of 3 samples for each group were 
considered; a student ‘t’ test was carried out for two-group comparisons and a p value of 
< 0.05 was considered statistically significant. 
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CHAPTER IV 
RESULTS 
Dmp1 KO mice display significant bone defects 
By using radiographs examination, we observed a significant delayed secondary 
ossification in epiphysis with more metaphyseal bone and dramatic reduction of  limb 
length in P10 KO mice ( Fig. 8 , right panel). Toluidine Blue Staining showed increased 
cartilage residue and more metaphyseal bone in the bone matrix ( purple color – Fig 9, 
right panel) in  10-day old KO mice. Furthermore, ( ALP) staining displayed expanded 
hypertrophic chondrocyte layers and highly active in cell differentiation from hypertrophic 
chondrocytes to osteoblasts ( dark blue color--Fig 10a, right panel) in KO mice at P10. 
Since there is active chondrocyte cell proliferation in the growth plate area and more bone 
in the metaphysis area, TRAP activity was examined to find if there is an equal rate of 
osteoclastic resorption too. Trap staining revelaed that there is no difference in TRAP 
activity between control and KO when compared in unit bone surface area ( Figure 10b, 
left and rightpanel). All the histological studies revelaed that the entire chondrogenesis is 
accelerated with active differentiation in KO mice.  
 
Cell Lineage Tracing  
Cell lineage tracing technique was used to investigate the mechanism for the dramatic 
increase of bone volume in the diaphysis and metaphysis but significant delay in 
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secondary ossfication and bone growth in KO mice. First DMP1 conventional knockout 
mice were generated (Feng et al., 2006). In order to trace the cell fate, the DMP1 KO mice 
were crossed with the Aggcrecan-CreERT2 (expressed in all cartilage cells) with R26RTomato 
mice. In this way, all the chondrocytes and their descendents were labelled with a  red 
color after the Cre event is activated by one-time tamoxifen injection. cell lineage tracing 
was combined with immunostaining for different proteins. 
 
First, osteogenic related proteins were used to examine the difference in bone formation 
between DMP1 KO and control mice. Collagen 1 (COL1) forms most of the organic 
component of bone. COL1 expression was reduced in the epiphysis and at the articular 
surface in KO mice, which may imply that cell transformation is affected because COL1 
forms most of the organic component of bone and its reduction signifies that the cells are 
still in the chondrogenesis phase. (Fig 11a, right panel). As expected, more COL1 
expression was seen in the metaphysis, indicating more bone matrix in the KO mice (Fig 
11b, right panel).  Next the expression of OPN, a glycoprotein which also forms the 
organic component of bone was studied. Like COL1, it is decreased in epiphysis area in 
KO mice (Fig 12a, right panel) and increased dramatically in bone matrix in metaphysis 
(Fig 12b, right panel). 
 
Next, transcription factors Runx2 and OSX were examined. Runx2 is a critical 
transcriptional factor for osteoblast differentiation. Osx is also an important transcriptional 
factor necessary for osteoblast activation. The expression for both was decreased in 
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epiphysis and metaphysis in the 10-day old KO mice (Runx2-Fig 13a, 13b, right panel), 
(OSX - Fig 14a, 14b, right panel). Then proliferation markers KI67, EDU were used to 
examine proliferative activity of cells right from induction of cre and the 24-hour 
proliferative activity of cells (EDU). Ki67 activity was higher in proliferative, 
prehypertrophic, hypertrophic chondrocytes (Fig 15a, right panel) and in bone (Fig 15b, 
right panel). This demonstrates that there is active cell division taking place, contributing 
to more chondrocyte cell numbers and bone cells in KO mice.  However, EDU activity 
was the same in control in epiphysis (Fig 16a, left panel) and metaphysis (Fig 16b, left 
panel). Early cartilage marker (COL2) which is expressed by all cartilage cells & late 
cartilage marker (COL10) which is specifically expressed by only hypertrophic 
chondrocytes was then examined. We found that the COL2 is similar in both epiphysis 
(Fig 17a, left and right panel) and in bone matrix (Fig 17b, left and right panel) when 
compared in unit surface area in control & KO mice. COL10 expression is higher in 
control in epiphysis (Fig 18a, left panel) and in bone matrix (Fig 18b, left panel). Lastly, 
osteocyte marker sclerostin (SOST) and endothelial Marker Endomucin were used to 
examine the cell maturation and vascularity. SOST expression is higher in control mice 
both in epiphysis (Fig 19a, left panel) and in cortical bone in diaphysis area (Fig 19b, left 
panel). Endothelial marker Endomucin expression is higher in epiphysis of control mice 
(Fig 20a, left panel). But the Endomucin activity is relatively similar in control and KO 
mice (Fig 20b, left and right panel) in unit square surface area. 
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Micro CT Analysis 
Micro – CT analysis was performed to determine the quality of bone formed in 
metaphysis. The structural cortical bone data revealed that there is more cortical bone and 
trabecular bone in KO mice (Fig21, right panel) however the bone appears more porous. 
Material density is the actual density of bone excluding the pores and Apparent density of 
the material is the density of bone including the pores. Quantitative analysis revealed that 
there was less material density for cortical (Fig 22) and trabecular bone (Fig 23) in KO 
mice. There was no significant difference in Apparent density in cortical bone between 
control and KO mice suggesting that the cortical bone formed is of relatively good quality 
in KO (Fig 24). However, the Apparent density of trabecular bone is significantly high in 
KO (Fig 25). Trabecular number is higher in KO mice which was expected due to more 
trabecular bone (Fig 26). Trabecular separation was less in KO mice which was expected 
because of more compacted trabecular bone in metaphyseal area (Fig 27). Cortical BV/TV 
is reduced in KO mice suggesting that though the bone appears dense, it is porous and 
therefore its bone volume is reduced (Fig 28). Trabecular BV/TV was high in KO mice 
which was expected due to more trabecular bone volume (Fig 29).  
 
Ex Vivo Metatarsal Organ Culture 
To investigate the role of phosphate on cell transformation and cell maturation 
independent of systemic factors, metatarsal organ culture studies were done for 8 days on 
P10 control and KO mice. This revealed that with increased β Glycero phosphate 
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concentration from 0 milli molar to 3 milli molar concentration, the secondary ossification 
center begins to form in KO mice like control mice (Fig 31) suggesting that phosphate 
plays a significant role in cell transformation and cell maturation. Lastly radiographs of 
KO mice revealed that the caudal vertebrae are smaller in size than control mice (Fig 30) 
and the reasons for this phenotypic change will be explored further. 
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Figure 8. Delayed Secondary Ossification: Representative X -ray images showed 
delayed secondary ossification and more metaphyseal bone in P10 KO mice (red arrow).  
 
   
     
 
Figure 9.  Toluidine Blue Staining: Representative Toluidine Blue images showed 
increased cartilage residue (purple) and more bone mass in metaphysis area in KO mice 
(black arrow heads) 
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Figure 10. a. ALP Staining: Representative Alkaline Phosphatase (ALP) stain images 
showed increased ALP activity (blue stain) in hypertrophic chondrocytes and metaphysis 
bone area in KO mice (yellow arrow heads). Figure 10.b. TRAP Staining: Tartarate – 
resistant acid phosphatase (TRAP) stain images show similar osteoclastic activity (red 
stain) in both control and KO per unit bone surface area (yellow arrow heads). 
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Figure 11a. Immunostaining COL1 in epiphysis:  COL 1 Immunostaining (green) co-
localized with cell lineage tracing by using Aggrecan-CreERT2 (red) showed decreased 
COL1 activity in articular surface and delayed secondary ossification (white arrow 
heads) in epiphysis in KO mice.  
. 
    
Figure 11b. Immunostaining COL1 in bone matrix: COL 1 immunostaining images 
showed more COL1 activity in bone matrix (white arrow heads) in metaphysis in KO 
mice. 
a 
COL1 COL1 CTR KO 
b 
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Figure 12a. Immunostaining OPN in epiphysis: Osteopontin (OPN) immunostaining 
(green) co-localized with cell lineage tracing by using Aggrecan-CreERT2 (red) showed 
decreased OPN activity and delayed secondary ossification (white arrow heads) in 
epiphysis in KO mice.   
 
 
             
 
Figure 12b. Immunostaining OPN in bone matrix:  Osteopontin (OPN) 
immunostaining images showed increased OPN activity in bone matrix in KO mice 
(white arrow heads).  
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Figure 13a. Immunostaining Runx2 in epiphysis:  Runt related transcription factor 
(Runx2) immunostaining (green) co-localized with cell lineage tracing by using 
Aggrecan-CreERT2 (red) and Dapi (blue) showed no Runx2 activity in articular surface 
and increased chondrogenesis (white arrow heads) in epiphysis in KO mice 
 
 
            
Figure 13b. Immunostaining Runx2 in bone: Runt related transcription factor (Runx2) 
immunostaining showed increased Runx2 activity in control in bone matrix (osteoblasts) 
than KO (white arrow heads). 
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Figure 14a. Immunostaining OSX in epiphysis: Osterix (OSX) immunostaining 
(green) co-localized with cell lineage tracing by using Aggrecan-CreERT2 (red) and Dapi 
(blue) showed more Osx activity (osteoblast) in proliferative and prehypertrophic 
chondrocytes (white arrow heads) in epiphysis in KO mice. 
 
 
 
                
      Figure 14b. Immunostaining OSX in bone: Osterix (OSX) immunostaining 
      images showed less Osx activity (osteoblast) in bone cells (white arrow heads) 
     in KO mice. 
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Figure 15a. Immunostaining KI67 in epiphysis: Ki67 immunostaining (green) co-
localized with cell lineage tracing by using Aggrecan-CreERT2 (red) and Dapi (blue) 
showed increased proliferative (KI67) activity in proliferative and pre-hypertrophic/ 
hypertrophic chondrocytes in epiphysis KO mice (white arrow heads) at P10.           
 
 
 
 
  
      
 
 
 
Figure 15b. Immunostaining KI67 in bone:  KI67 immunostaining images showed 
increased proliferative (KI67) activity of osteogenic cells on the bone surface in KO 
mice (white arrow heads). 
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Figure 16a. Immunostaining EDU in epiphysis: EDU immunostaining (green) co-
localized with cell lineage tracing by using Aggrecan-CreERT2 (red) and Dapi (blue) 
showed increased proliferative (EDU) activity in epiphysis in proliferative and pre-
hypertrophic in control mice (white arrow heads). 
 
 
 
 
                
Figure 16b. Immunostaining EDU in bone: EDU positive cells in bone marrow and 
the osteogenic cells on the bone surface in metaphysis in 10-day old control mice were 
much more than the KO mice. 
(white arrow heads). 
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Figure 17a. Immunostaining Col2 in epiphysis: collagen 2 (COL2) immunostaining 
(green) co-localized with cell lineage tracing by using Aggrecan-CreERT2 (red) showed 
similar COL2 activity in both control and KO mice at P10 in epiphysis and proliferative 
chondrocytes (white arrow heads).      
 
          
Figure 17b. Immunostaining Col2 in bone: There was no significant difference in the 
cartilage residue reflected by COL2 immunostaining in metaphysis (bone matrix) both 
10-day old control and KO mice (white arrow heads). 
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Figure 18a. Immunostaining Col10 in growth plate: Collagen 10 (COL10) 
immunostaining co-localized with cell lineage tracing by using Aggrecan-CreERT2 (red) 
showed a strong COL10 expression in the hypertrophic chondrocytes (white arrows 
heads) in the control growth plate, but an absence in the age-matched KO mice.  
       
 
 
 
 
    
 
 
Figure 18b. Immunostaining Col10 in bone:  COL10 expression was also higher in the 
metaphysis (bone matrix) in control compared with KO mice (white arrows heads).  
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Figure 19a. Immunostaining SOST in epiphysis: Sclerostin (SOST) immunostaining 
(green) co-localized with cell lineage tracing by using Aggrecan-CreERT2 (red) and Dapi 
(blue) revealed a positive expression of Sclerostin in the secondary ossification in 
control mice, while there was no sign for an ossification in the epiphysis in the KO mice  
(white arrows heads). 
 
 
            
Figure 19b. Immunostaining SOST in bone: SOST was highly expressed by 
osteocytes in the osteocytes in the control cortical bone, but was barely detected in the 
KO mice (white arrows heads). 
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Figure 20a. Immunostaining Endomucin in epiphysis: Endomucin immunostaining 
(green) co-localized with cell lineage tracing by using Aggrecan-CreERT2 (red) and Dapi 
(blue) revealed a positive expression of Endomucin in the secondary ossification in 
control mice, while there was no sign of any vascularity in the epiphysis in the KO mice  
(white arrows heads). 
 
 
           
 
Figure 20b. Immunostaining Endomucin in bone: Endomucin immunostaining 
images showed similar Endomucin activity in both control and KO mice per unit bone 
surface area (white arrow heads). 
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Figure 21. Micro CT Imaging Data: From the above micro – CT data, we can clearly 
observe that the overall cortical and trabecular bone volume seems to be more in KO 
than Control, although most of bone is porous in KO (red arrows) at P10. 
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Figure 22. Material Density for Cortical Bone Graph: Quantitative analysis of 
Material density for cortical bone showed a statistically significant difference between 
control and KO samples (n=3, P < 0.05).    
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Figure 23. Apparent Density for Cortical Bone Graph: Quantitative analysis of 
Apparent density for cortical bone showed a statistically significant difference between 
control and KO samples (n=3, P < 0.01).   
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Figure 24. Material Density for Trabecular Bone Graph: Quantitative analysis of 
Apparent density for cortical bone showed no significant difference between control and 
KO samples (n=3, P > 0.05).    
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Figure 25. Apparent Density for Trabecular Bone Graph: Quantitative analysis of 
Apparent density for trabecular bone showed statistically significant difference between 
control and KO samples (n=3, P < 0.01).    
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Figure 26. Trabecular number comparison graph:  Quantitative analysis of trabecular 
number showed statistically significant differences between control and KO samples 
(n=3; P value < 0.001).      
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Figure 27. Trabecular separation comparison graph:  Quantitative analysis of 
trabecular separation showed statistically significant differences between control and KO 
samples (n=3; P value < 0.01).      
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Figure 28. Cortical Bone BV/TV Graph:  Quantitative analysis of cortical BV/TV 
showed statistically significant differences between control and KO samples (n=3; P 
value < 0.01).      
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Figure 29. Trabecular bone BV/TV Graph:  Quantitative analysis of trabecular 
BV/TV showed statistically significant differences between control and KO samples 
(n=3; P value < 0.01).      
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Figure 30. Metatarsal Radiographic Data: The white arrow heads are pointing to the 
metatarsals which are dissected and cultured for 8 days in culture medium. Of 
significance is the tail vertebra which are reduced in size in KO than Control mice (red 
arrows). 
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Figure 31. Metatarsal Organ Culture: The above figures represent with increase in 
phosphate concentration from 0milli Molar concentration to 3 millimolar concentration 
the secondary ossification center in epiphysis begins to form in the KO mice in the same 
manner as control in metatarsals in organ culture. 
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 DMP1, a non-collagenous phosphoprotein, is highly expressed in osteocytes. The DMP1 
mutation in humans or the deletion of Dmp1 in mice leads to ARHR (Feng et al., 2006; 
Ye et al., 2005). It is clear that a low phosphorous level is responsible for shortening of 
long bones and the delayed secondary ossification formation in Dmp1 null epiphyses. 
However, it is not understood why accumulation or ‘persistence’ of hypertrophic 
chondrocytes in the Dmp1 null growth plate occurs. One of the speculations was that the 
reduced apoptosis in the Dmp1 null hypertrophic chondrocytes leads to a failure in 
replacement of cartilage by bone tissue. Yet, this assumption cannot explain why there is 
more bone mass in the Dmp1 null metaphysis. In this study, cell lineage tracing technique 
was combined with multiple imaging and molecular study approaches to address why and 
how DMP1 null mice develop malformed long bones, in which there is an accumulated 
hyper chondrocyte layer and an expanded metaphysis. Key findings are (1) there is a sharp 
increase in the entire null cartilage layers, including proliferative, prehypertrophic, and 
hypertrophic zones of the growth plate (i.e., the low Pi level leads to more chondrocyte 
cell numbers); (2) there was an increase in Ki67 positive cells in null growth plate, 
suggesting that there is more cell proliferation in the null mice; (3) there was an increase 
in ALP activity in hypertrophic chondrocytes, suggesting a more active chondrocyte 
activity in the null mice; (4) there are more chondrocyte-derived bone cells with more 
 CHAPTER V 
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cartilage residues in the null metaphysis, indicating an acceleration of the cell 
transformation of chondrocytes into bone cells; (5) there is an increase in osteoblast bone 
markers such as COL1 and OPN expression but a great reduction in osteocyte markers 
like SOST in the null bone, indicating a defect in  bone cell maturation; and (6)  there is a 
unique role of Pi levels in epiphyses: a low Pi inhibits secondary ossification in vivo and 
an acceleration of the secondary ossification by Pi ex vivo, which raises an issue that Pi 
regulates the transformation from chondrocytes into bone cell in epiphyses in a different 
manner from that in the growth plate. 
 A notable and novel finding obtained in this study was that hypophosphatemia 
accelerates, instead of inhibits, chondrogenesis and the transformation of chondrocytes 
into bone cells in the growth plate. Because of a sharp acceleration in both chondrogenesis 
and osteogenesis in growth plates and metaphysis due to low Pi levels, cartilage matrices 
cannot be efficiently removed and the speed of maturation of osteoblasts into osteocytes 
cannot catch. As a result, the Dmp1 null mice display lengthened chondrocyte zones and 
expanded metaphysis with a great increase in immature osteoblasts and cartilage residues. 
Of note, this new finding does not exclude the impact of other factors (such as a moderate 
reduction in apoptosis and osteoclast number) on development of the Dmp1 null 
phenotype (Ye et al., 2005; R. Zhang et al., 2011). However, the potent role of a low Pi 
on chondrogenesis and cell transformation is the most critical cause for the growth plate 
and metaphysis null phenotype. 
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Because of free penetration of Pi through the placenta, the Dmp1 KO phenotype begins 
postnatally (Ye et al., 2005). Based on the ex vivo data (Fig 31), it is clear that secondary 
ossification formation is completely dose-dependent on phosphorus levels with no 
apparent difference between WT and KO metatarsals. Similar to growth plates, there are 
more active chondrogenesis in the KO than that in the WT epiphysis based on multiple 
assays described in (Figs 15a,17a – right panel) including Ki67 (reflecting cell 
proliferation), Col 2 (chondrocyte marker) and tomato (indicating chondrocyte activity). 
In contrast, there is a much smaller bone mass with fewer red bone cells in the KO 
epiphysis than that in the WT epiphysis. The bone markers such as Col 1, OPN and SOST 
are fewer in the KO epiphysis than those in the WT epiphysis (Figs 11a,12a,18a – right 
panel). These data seem to support the notion that a low level of Pi inhibits the cell 
transformation of chondrocytes into bone cells in the epiphysis. Although we do not 
understand why and how this inhibition occurs in the epiphysis, this unexpected event in 
the KO epiphysis may help explain why epiphysis development behinds metaphysis 
development in the same environment. 
. 
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CHAPTER VI 
CONCLUSIONS AND FUTURE DIRECTIONS 
While the current dogma maintains that hypertrophic chondrocytes undergo apoptosis, 
recent evidence suggests otherwise i.e. that these chondrocytes directly transform into 
bone cells, rather than undergo apoptosis, during endochondral ossification. Using cell 
lineage tracing techniques in conventional knockout animal models such as the DMP1 
knockout, can be explained the actual fate of hypertrophic chondrocytes in endochondral 
bone formation: in the conventional phenotype, these chondrocytes seem to differentiate 
into immature bone cells and form bone relatively early, as evidenced by shorter-than-
normal or ‘stunted’ long bones presenting with marked metaphyseal expansion in the 
metaphysis but the cell transformation seems to be affected in epiphysis which explains 
why there is delayed secondary ossification in epiphysis in the same low phosphate 
environment despite accelerated chondrogenesis.. However, further elucidation on the 
genetic and molecular underpinnings, and mechanisms, that consign chondrocytes to such 
fate (during endochondral bone development) is needed. 
Future directions include analyzing the effect of high phosphate on skeleton, 
developmentally, at 3 weeks, 7 weeks and 3 months. 
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Three-week-old mice will subsist on a phosphate-rich diet over the next 4 weeks and then 
sacrificed at 7 weeks of age. Similarly, 2-month-old mice will be given tamoxifen to 
activate Aggcrecan cre after which they subsist on a phosphate-rich diet over 4 weeks, 
and, at 3 months of age, will be sacrificed. 
Using this approach, the effect of high phosphate on cell transformation can be more 
selectively traced in both epiphysis and metaphysis. 
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